Plasma polypyrrole implants recover motor function in rats after spinal cord transection.

We studied the use of three biocompatible materials obtained by plasma polymerization of pyrrole (PPy), pyrrole doped with iodine (PPy/I) and a copolymer formed with pyrrole and polyethylene glycol (PPy/PEG), implanted, separately, after a complete spinal cord transection in rats. Motor function assessed with the BBB scale and somatosensory evoked potentials (SEPs) in the implanted rats were studied. Results showed that the highest motor recovery was obtained in rats with PPy/I implants. They also showed a significant reduction in the latency of SEPs. Histological analyses showed no signs of implant rejection; on the contrary, implants based on PPy improved the SEPs conduction and motor function after lesion.

[Clinical characteristics of the late-onset epilepsy in Mexico to the beginning of the new millennium: 455 cases]. / Características clínicas de la epilepsia de inicio tardío en México al principio del nuevo milenio: 455 casos.

INTRODUCTION: Epilepsy is a multifactorial disorder, and several factors can modify its prevalence in different regions. Among these, local culture, public health policies and survival rate can be cited. Alongside, the cause of epilepsy may be different according to time and geographic registries. In Mexico, neurocysticercosis remains a leading cause of seizures. Nonetheless, lifestyle changes and the increase in life expectancy have fostered the incidence of stroke. Both diseases are the main underlying disorders causing epilepsy in Mexico. Lately, their respective incidence is being reversed, and therefore their role is gradually interchanging. OBJECTIVES: To describe and assess the epidemiological and clinical features of a sample of Mexican patients with late-onset seizures. MATERIAL AND METHODS: A group of 455 patients aged over 20 years old was recruited from ten different centers nationwide. The study included patients with onset of epilepsy from year 2000 on, and clinical features of seizures were recorded for every patient, electroencephalogram (EEG) and brain computed tomography (CT) were performed. RESULTS: No gender-related differences were observed. Age distribution was as follows: the highest incidence occurred in the third decade of life and 18% of the patients were aged above 60 years old. Generalized seizures were recorded in 49% of the patients. Pharmacological management used a single drug in 83% of the patients and the most frequently used drug was diphenylhydantoine (PHT) and the second was carbamazepine (CBZ). Abnormal electroencephalographic findings were recoded in 66% of the cases. Concerning etiologies, the first cause was neurocysticerosis in 21% of the cases, followed by stroke in 17% of them. No cause could be found in 49% of the patients. These findings slightly differ from those of other centers in developed countries. CONCLUSIONS: In the last decades, the societal changes in the country have greatly influence the shift in the underlying causes of late-onset seizures. Even if neurocysticercosis stands still as the first cause, its frequency has declined by more than 50% while the increase of stroke incidence has boosted its etiological role and their difference is now statistically non-significant.

Prevalence of migraine in Latin America.

OBJECTIVE: To determine the 1-year point prevalence of migraine among residents > or =15 years old in 12 Latin American urban communities, and record medical consultation preferences of the identified migraineurs. BACKGROUND: Prevalence of migraine with or without aura in Latin American urban communities has not been established by large-scale population studies. METHODS: A validated face-to-face interview questionnaire based on International Headache Society criteria was completed for all headache sufferers within selected households, in a cross-sectional study. The randomly selected populations were representative of urban communities from the six participating Latin American countries. The questionnaire used was identical in each of the six participating countries. RESULTS: Of the 8618 people available for screening, 62% reported headache and 2637 completed interview questionnaires. Age-adjusted 1-year prevalence of migraine with or without aura for each country was (female/male, %): Argentina 6.1/3.8, Brazil 17.4/7.8, Colombia 13.8/4.8, Ecuador 13.5/2.9, Mexico 12.1/3.9, and Venezuela 12.2/4.7. Migraine prevalence was highest in women aged 30 to 50 years. In the year prior to the study, 42% of individuals interviewed and identified with migraine reported consulting a health professional about their headaches, most frequently (14%) a general practitioner. No previous diagnosis of migraine was reported by 65% of individuals with headache. CONCLUSIONS: In agreement with previous epidemiologic reports, migraine is also a common disorder in Latin American urban communities and predominantly affects women aged 30 to 50 years. Consultation preferences are also similar to those of previous reports.

Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries.

OBJECTIVE: The objective of this study was to document the clinical characteristics of migraine and patterns of medication use in residents > or =15 years old in 12 Latin American urban communities. BACKGROUND: Few large-scale population studies have established the symptoms and disability associated with migraine with or without aura in Latin American urban communities or the pattern of medication use in these regions. METHODS: In this study, subjects in 12 urban communities, from 6 Latin American countries, were surveyed with a validated face-to-face interview questionnaire based on International Headache Society criteria for migraine. The questionnaire was completed during face-to-face interviews with headache sufferers within selected households and included questions about migraine symptoms, migraine-related disability, and the use of health-care resources and medications to treat migraines. RESULTS: Of the 8618 people available for screening, 62% suffered from headaches. Of individuals with migraine, 42% reported consulting a health-care professional about their headaches. Of the migraineurs, 94.2% reported moderate to severe pain. Associated symptoms of nausea or vomiting, photophobia, phonophobia, and osmophobia were common during migraine attacks in 30.3, 76.4, 85.1, and 47.7% of subjects, respectively. The majority of subjects suffered between one and eight migraines each month. Although no previous diagnosis of migraine was reported by 65% of headache sufferers, migraineurs lost an average of 8 days in the preceding 3 months in any of the following areas: school, work, household chores, and/or social, family, or leisure activities. The agents used most widely to treat migraine were paracetamol and salicylates, while nonsteroidal anti-inflammatory drugs, dypirone, and ergotamines were also commonly used. Medication use varied widely among countries, but was predominantly nonprescription. CONCLUSIONS: Migraine is a common disorder in Latin American urban communities imposing significant burden on individuals, families, and communities. The magnitude of the impact and the range of activities affected by migraine are similar to those of previous reports in other regions. The preponderance of nonprescription medications and the scarcity of migraine-specific triptans from the study findings are especially striking.

Prevalence and risk factors associated with the presence of peripheral neuropathy in patients with hepatitis C virus infection.

OBJECTIVES: To determine the frequency and risk factors associated with peripheral neuropathy in a population of patients with hepatitis C virus infection. METHODS: Cross-sectional study. Electrophysiological assessment included bilateral motor and sensory conduction studies of four limbs. RESULTS: Thirty-one cases and 31 control subjects were studied. Eighteen patients (58%) from the group of patients infected with the hepatitis C virus had evidence of neuropathy. Only 3 (10%) persons from the control group exhibited neuropathy. Among the risk factors for neuropathy in the patients infected with hepatitis C virus, we found the following: positive rheumatoid factor, cryoglobulinemia, and cirrhosis or active hepatitis. Other risk factors were advanced age, prolonged time of evolution, high viral load of the hepatitis C virus, and low complement. CONCLUSIONS: The frequency of neuropathy encountered in our study was high (58%). In our study, a positive rheumatoid factor, cryoglobulins, and a high viral load were also associated with the presence of peripheral neuropathy. A high viral load could express possible direct viral damage.